These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33485676)

  • 61. Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration.
    Markovic-Denic L; Zdravkovic M; Ercegovac M; Djukic V; Nikolic V; Cujic D; Micic D; Pekmezovic T;
    J Infect Public Health; 2022 Jul; 15(7):739-745. PubMed ID: 35691217
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.
    McEllistrem MC; Clancy CJ; Buehrle DJ; Singh N; Lucas A; Sirianni V; Decker BK
    PLoS One; 2021; 16(3):e0248347. PubMed ID: 33735264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Asymptomatic SARS-CoV-2 infection among healthcare workers in a non-COVID-19 teaching university hospital.
    Mukhtar A; Afishawy M; Alkhatib E; Hosny M; Ollaek M; Elsayed A; Salem MR; Ghaith D
    J Public Health Res; 2021 Apr; 10(3):. PubMed ID: 33794599
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seroprevalence of SARS-CoV-2 IgG antibodies among workers in the University Hospital of Guadeloupe.
    Palmeri V; Le Turdu-Chicot C; Garin B; Auguste A; Roger PM
    Clin Ter; 2021 Sep; 172(5):461-466. PubMed ID: 34625780
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19.
    Baxendale HE; Wells D; Gronlund J; Nadesalingham A; Paloniemi M; Carnell G; Tonks P; Ceron-Gutierrez L; Ebrahimi S; Sayer A; Briggs JAG; Ziong X; Nathan JA; Grice G; James LC; Luptak J; Pai S; Heeney JL; Lear S; Doffinger R
    J Crit Care Med (Targu Mures); 2021 Jul; 7(3):199-210. PubMed ID: 34722923
    [TBL] [Abstract][Full Text] [Related]  

  • 67. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Evaluation of Healthcare Professionals in Contact with Patients Diagnosed with COVID-19 Detected Outside of the Pandemic Service in our Hospital].
    Korkmaz D; Konya P; Tünay H; Demirtürk N
    Mikrobiyol Bul; 2021 Apr; 55(2):194-206. PubMed ID: 33882651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The impact of government pandemic policies on the vulnerability of healthcare workers to SARS-CoV-2 infection and mortality in Jakarta Province, Indonesia.
    Agustina R; Rianda D; Lamuri A; Ekawidyani KR; Siregar DAS; Sari DS; Wulan PM; Devana ND; Syam AF; Rahyussalim AJ; Handayani DO; Widyastuti W; Shankar AH; Salama N
    Ann Med; 2023; 55(2):2293306. PubMed ID: 38206905
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of anti-SARS-CoV-2 antibodies and associated factors in healthcare workers of a Mexican Covid-19 hospital.
    Herrera-Ortiz A; Rojas-Delgado HU; García-Cisneros S; Xibille-Friedmann DX; Martínez-Barnetche J; Olamendi-Portugal M; González-Sánchez HM; Sánchez-Alemán MÁ
    Salud Publica Mex; 2022 Jul; 64(4, jul-ago):348-356. PubMed ID: 36130357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
    Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
    Front Public Health; 2022; 10():832003. PubMed ID: 35400056
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determinants of seropositivity for SARS-CoV-2 in hospital staff in the second wave of the pandemic in Slovenia.
    Socan M; Prosenc K; Kukec A; Zaletel-Kragelj L; Remec T; Grmek-Kosnik I
    Int J Occup Med Environ Health; 2022 Oct; 35(5):571-584. PubMed ID: 35856815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study.
    Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A
    BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Characteristics and Mortality of Health-Care Workers With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Mexico City.
    Guerrero-Torres L; Caro-Vega Y; Crabtree-Ramírez B; Sierra-Madero JG
    Clin Infect Dis; 2021 Jul; 73(1):e199-e205. PubMed ID: 32986118
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.
    Lapić I; Rogić D; Šegulja D; Kralik Oguić S; Knežević J
    Croat Med J; 2020 Dec; 61(6):485-490. PubMed ID: 33410294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.
    Malagón-Rojas JN; Mercado-Reyes M; Toloza-Pérez YG; Parra Barrera EL; Palma M; Muñoz E; López R; Almentero J; Rubio VV; Ibáñez E; Téllez E; Delgado-Murcia LG; Jimenez CP; Viasus-Pérez D; Galindo M; Lagos L;
    Occup Environ Med; 2022 Jun; 79(6):388-395. PubMed ID: 34740981
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High anti-SARS-CoV-2 antibody seroprevalence in healthcare workers in an Irish university teaching hospital.
    Leonard A; Prior AR; Reilly P; Murray C; Brien MO; Maguire G; Ennis D; Reid A; Rakovac A; Boran G
    Ir J Med Sci; 2022 Jun; 191(3):1023-1028. PubMed ID: 34195921
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection.
    Yadav RM; Pate A; Shankarkumar A; Athalye S; Shinde S; Bargir UA; Pate M; Ganpule M; Pruthi M; Patil H; Madkaikar MR
    J Epidemiol Glob Health; 2021 Sep; 11(3):283-288. PubMed ID: 34514761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.